IPO - Beam Therapeutics Inc.

Form Type: 8-K

Filing Date: 2025-03-10

Corporate Action: Ipo

Type: New

Accession Number: 000119312525051072

Filing Summary: On March 10, 2025, Beam Therapeutics Inc. entered into an underwriting agreement relating to an underwritten offering of 16,151,686 shares of its common stock and pre-funded warrants to purchase 1,404,988 shares of common stock. The offering price for the shares is set at $28.48 each, while the pre-funded warrants are priced at $28.47 each of common stock. The underwriters, consisting of several major financial institutions, will purchase the shares at a discounted price of $26.7712 per share and the pre-funded warrants at $26.7612 per share. The expected net proceeds from this offering will amount to approximately $469.7 million, which will be allocated for further development of the company's technology, research, development, and potential commercialization activities. The shares and warrants will be issued under an effective shelf registration statement. The closing of the offering is anticipated to occur on or about March 11, 2025, pending customary closing conditions. The document includes details on the underwriting agreement along with potential limitations on the exercise of pre-funded warrants and other pertinent provisions.